Syndecans: From peripheral coreceptors to mainstream regulators of cell behaviour

International Journal of Experimental Pathology

Volumn 96, Issue 1, 2015, Pages 1-10

  Couchman, John R ^a   Gopal, Sandeep ^a   Lim, Hooi Ching ^a   Nørgaard, Steffen ^a   Multhaupt, Hinke A B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cytoskeleton; Glycosaminoglycan; Heparan sulphate; Proteoglycan

Indexed keywords

SYNDECAN; CELL SURFACE RECEPTOR; LIGAND;

CELL FUNCTION; CELL MOTILITY; INFLAMMATION; MELANOMA CELL; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; DEFICIENCY; GENETICS; GENOTYPE; HUMAN; KNOCKOUT MOUSE; METABOLISM; NEOPLASM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; GENOTYPE; HUMANS; INFLAMMATION; LIGANDS; MICE, KNOCKOUT; NEOPLASMS; PHENOTYPE; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SYNDECANS;

EID: 84923437834     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12112     Document Type: Review

References (83)

1. Alexopoulou A.N., Multhaupt H.A. & Couchman J.R. (2007) Syndecans in wound healing, inflammation and vascular biology. Int. J. Biochem. Cell Biol. 39, 505-528.
2. Baietti M.F., Zhang Z., Mortier E. et al. (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685.
3. Bass M.D., Morgan M.R., Roach K.A., Settleman J., Goryachev A.B. & Humphries M.J. (2008) p190RhoGAP is the convergence point of adhesion signals from alpha 5 beta 1 integrin and syndecan-4. J. Cell Biol. 181, 1013-1026.
4. Beauvais D.M. & Rapraeger A.C. (2004) Syndecans in tumor cell adhesion and signaling. Reprod. Biol. Endocrinol. 2, 3.
5. Bertrand J., Stange R., Hidding H. et al. (2013) Syndecan 4 supports bone fracture repair, but not fetal skeletal development, in mice. Arthritis Rheum. 65, 743-752.
6. Bullock S.L., Fletcher J.M., Beddington R.S. & Wilson V.A. (1998) Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12, 1894-1906.
7. Campos-Xavier A.B., Martinet D., Bateman J. et al. (2009) Mutations in heparan sulfate-proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia. Am. J. Hum. Genet. 84, 760-770.
8. Chakravarti R. & Adams J.C. (2006) Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates. BMC Genom. 7, 83.
9. Chalkiadaki G., Nikitovic D., Berdiaki A. et al. (2009) Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism. Int. J. Biochem. Cell Biol. 41, 1323-1331.
10. Chanana B., Steigemann P., Jäckle H. & Vorbrüggen G. (2009) Reception of Slit requires only the chondroitin-sulphate-modified extracellular domain of Syndecan at the target cell surface. Proc. Natl Acad. Sci. USA 106, 11984-11988.
11. Chaudhuri P., Colles S.M., Fox P.L. & Graham L.M. (2005) Protein kinase Cdelta-dependent phosphorylation of syndecan-4 regulates cell migration. Circ. Res. 97, 674-681.
12. Chen K. & Williams K.J. (2013) Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor. J. Biol. Chem. 288, 13988-13999.
13. Couchman J.R. (2010) Transmembrane signaling proteoglycans. Annu. Rev. Cell Dev. Biol. 26, 89-114.
14. Culp L.A., Laterra J., Lark M.W., Beyth R.J. & Tobey S.L. (1986) Heparan sulphate proteoglycan as mediator of some adhesive responses and cytoskeletal reorganization of cells on fibronectin matrices: independent versus cooperative functions. Ciba Found. Symp. 124, 158-183.
15. Deepa S.S., Yamada S., Zako M., Goldberger O. & Sugahara K. (2004) Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279, 37368-37376.
16. Denhez F., Wilcox-Adelman S.A., Baciu P.C. et al. (2002) Syndesmos, a syndecan-4 cytoplasmic domain interactor, binds to the focal adhesion adaptor proteins paxillin and Hic-5. J. Biol. Chem. 277, 12270-12274.
17. Dovas A., Yoneda A. & Couchman J.R. (2006) PKCalpha-dependent activation of RhoA by syndecan-4 during focal adhesion formation. J. Cell Sci. 119, 2837-2846.
18. Dovas A., Choi Y., Yoneda A. et al. (2010) Serine 34 phosphorylation of rho guanine dissociation inhibitor (RhoGDIalpha) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion. J. Biol. Chem. 285, 23296-23308.
19. Echtermeyer F., Streit M., Wilcox-Adelman S. et al. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107, R9-R14.
20. Echtermeyer F., Bertrand J., Dreier R. et al. (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med. 15, 1072-1076.
21. Elenius V., Götte M., Reizes O., Elenius K. & Bernfield M. (2004) Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J. Biol. Chem. 279, 41928-41935.
22. Fears C.Y. & Woods A. (2006) The role of syndecans in disease and wound healing. Matrix Biol. 25, 443-456.
23. Filmus J. & Capurro M. (2013) Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J. 280, 2471-2476.
24. Filmus J. & Capurro M. (2014) The role of glypicans in hedgehog signaling. Matrix Biol. 35, 248-252.
25. Fux L., Ilan N., Sanderson R.D. & Vlodavsky I. (2009) Heparanase: busy at the cell surface. Trends Biochem. Sci. 34, 511-519.
26. Ghossoub R., Lembo F., Rubio A. et al. (2014) Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat. Commun. 5, 3477.
27. Gopal S., Bober A., Whiteford J.R., Multhaupt H.A., Yoneda A. & Couchman J.R. (2010) Heparan sulfate chain valency controls syndecan-4 function in cell adhesion. J. Biol. Chem. 285, 14247-14258.
28. Götte M. (2003) Syndecans in inflammation. FASEB J. 17, 575-591.
29. Gysi S., Rhiner C., Flibotte S., Moerman D.G. & Hengartner M.O. (2013) A network of HSPG core proteins and HS modifying enzymes regulates netrin-dependent guidance of D-type motor neurons in Caenorhabditis elegans. PLoS ONE 8, e74908.
30. Herum K.M., Lunde I.G., Skribic B. et al. (2013) Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress. J. Mol. Cell. Cardiol. 54, 73-81.
31. Hienola A., Tumova S., Kulesskiy E. & Rauvala H. (2006) N-syndecan deficiency impairs neural migration in brain. J. Cell Biol. 174, 569-580.
32. Hynes R.O. (2004) The emergence of integrins: a personal and historical perspective. Matrix Biol. 23, 333-340.
33. Iozzo R.V. & Sanderson R.D. (2011) Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J. Cell Mol. Med. 15, 1013-1031.
34. Ishiguro K., Kadomatsu K., Kojima T. et al. (2000) Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J. Biol. Chem. 275, 5249-5252.
35. Ishikawa T. & Kramer R.H. (2010) Sdc1 negatively modulates carcinoma cell motility and invasion. Exp. Cell Res. 316, 951-965.
36. Johnson K.G., Ghose A., Epstein E., Lincecum J., O'Connor M.B. & Van Vactor D. (2004) Axonal heparan sulfate proteoglycans regulate the distribution and efficiency of the repellent slit during midline axon guidance. Curr. Biol. 14, 499-504.
37. Kato M., Saunders S., Nguyen H. & Bernfield M. (1995) Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells. Mol. Biol. Cell 6, 559-576.
38. Kehoe O., Kalia N., King S. et al. (2014) Syndecan-3 is selectively pro-inflammatory in the joint and contributes to antigen-induced arthritis in mice. Arthritis. Res. Ther. 16, R148.
39. Khotskaya Y.B., Dai Y., Ritchie J.P. et al. (2009) Syndecan-1 is required for robust growth, vascularization and metastasis of myeloma tumors in vivo. J. Biol. Chem. 284, 26085-26095.
40. Kinnunen T., Kaksonen M., Saarinen J., Kalkkinen N., Peng H.B. & Rauvala H. (1998) Cortactin-Src kinase signaling pathway is involved in N-syndecan-dependent neurite outgrowth. J. Biol. Chem. 273, 10702-10708.
41. Koo B.K., Jung Y.S., Shin J. et al. (2006) Structural basis of syndecan-4 phosphorylation as a molecular switch to regulate signaling. J. Mol. Biol. 355, 651-663.
42. Kovalszky I., Hjerpe A. & Dobra K. (2014) Nuclear translocation of heparan sulfate proteoglycans and their functional significance. Biochim. Biophys. Acta 1840, 2491-2497.
43. Lendorf M.E., Manon-Jensen T., Kronqvist P., Multhaupt H.A. & Couchman J.R. (2011) Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. J. Histochem. Cytochem. 59, 615-629.
44. Lim H.C. & Couchman J.R. (2014) Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases. Biochim. Biophys. Acta 1840, 2482-2490.
45. Lin X., Wei G., Shi Z. et al. (2000) Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224, 299-311.
46. Manon-Jensen T., Itoh Y. & Couchman J.R. (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 277, 3876-3889.
47. Manon-Jensen T., Multhaupt H.A. & Couchman J.R. (2013) Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains. FEBS J. 280, 2320-2331.
48. Morgan M.R., Hamidi H., Bass M.D., Warwood S., Ballestrem C. & Humphries M.J. (2013) Syndecan-4 phosphorylation is a control point for integrin recycling. Dev. Cell 24, 472-485.
49. Multhaupt H.A., Yoneda A., Whiteford J.R., Oh E.S., Lee W. & Couchman J.R. (2009) Syndecan signaling: when, where and why? J. Physiol. Pharmacol. 60(Suppl 4), 31-38.
50. Munesue S., Kusano Y., Oguri K. et al. (2002) The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones. Biochem. J. 363, 201-209.
51. Munesue S., Yoshitomi Y., Kusano Y. et al. (2007) A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J. Biol. Chem. 282, 28164-28174.
52. Murakami M., Horowitz A., Tang S., Ware J.A. & Simons M. (2002) Protein kinase C (PKC) delta regulates PKCalpha activity in a Syndecan-4-dependent manner. J. Biol. Chem. 277, 20367-20371.
53. Nobes C.D. & Hall A. (1999) Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144, 1235-1244.
54. Oh E.S., Woods A. & Couchman J.R. (1997) Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272, 8133-8136.
55. Oh E.S., Woods A., Lim S.T., Theibert A.W. & Couchman J.R. (1998) Syndecan-4 proteoglycan cytoplasmic domain and phosphatidylinositol 4, 5-bisphosphate coordinately regulate protein kinase C activity. J. Biol. Chem. 273, 10624-10629.
56. Okina E., Grossi A., Gopal S., Multhaupt H.A. & Couchman J.R. (2012) Alpha-actinin interactions with syndecan-4 are integral to fibroblast-matrix adhesion and regulate cytoskeletal architecture. Int. J. Biochem. Cell Biol. 44, 2161-2174.
57. Pal-Ghosh S., Tadvalkar G., Jurjus R.A., Zieske J.D. & Stepp M.A. (2008) BALB/c and C57BL6 mouse strains vary in their ability to heal corneal epithelial debridement wounds. Exp. Eye Res. 87, 478-486.
58. Peterson S.B. & Liu J. (2013) Multi-faceted substrate specificity of heparanase. Matrix Biol. 32, 223-227.
59. Pilia G., Highes-Benzie R.M., MacKenzie A. et al. (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12, 241-247.
60. Ramani V.C., Pruett P.S., Thompson C.A., DeLucas L.D. & Sanderson R.D. (2012) Heparan sulfate chains of syndecan-1 regulate ectodomain shedding. J. Biol. Chem. 287, 995299-61.
61. Sarrazin S., Lamanna W.C. & Esko J.D. (2011) Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 1, 3.
62. Saunders S., Jalkanen M., O'Farrell S, Bernfield M. (1989) Molecular cloning of syndecan, an integral membrane proteoglycan. J. Cell Biol. 108, 1547-1556.
63. Schulz J.G., Annaert W., Vandekerckhove J., Zimmermann P., De Strooper B. & David G. (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J. Biol. Chem. 278, 48651-48657.
64. Schulz J.G., Ceulemans H., Caussinus E. et al. (2011) Drosophila syndecan regulates tracheal cell migration by stabilizing Robo levels. EMBO Rep. 12, 1039-1046.
65. Schwabiuk M., Coudiere L. & Merz D.C. (2009) SDN-1/syndecan regulates growth factor signaling in distal tip cell migrations in C. elegans. Dev. Biol. 334, 235-342.
66. Steigemann P., Molitor A., Fellert S., Jäckle H. & Vorbrüggen G. (2004) Heparan sulfate proteoglycan syndecan promotes axonal and myotube guidance by slit/robo signaling. Curr. Biol. 14, 225-230.
67. Stepp M.A., Gibson H.E., Gala P.H. et al. (2002) Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 115, 4517-4531.
68. Stewart M.D. & Sanderson R.D. (2014) Heparan sulfate in the nucleus and its control of cellular functions. Matrix Biol. 35, 56-59.
69. Stickens D., Zak B.M., Rougier N., Esko J.D. & Werb Z. (2005) Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132, 5055-5068.
70. Strand M.E., Herum K.M., Rana Z.A. et al. (2013) Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart. FEBS J. 280, 2228-2247.
71. Sun D., Mcalmon K.R., Davies J.A., Bernfield M. & Hay E.D. (1998) Simultaneous loss of expression of syndecan-1 and E-cadherin in the embryonic palate during epithelial-mesenchymal transformation. Int. J. Dev. Biol. 42, 733-736.
72. Tamkun J.W., DeSimone D.W., Fonda D. et al. (1986) Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46, 271-282.
73. Tanino Y., Chang M.Y., Wang X. et al. (2012) Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 47, 196-202.
74. Teng Y.H., Aquino R.S. & Park P.W. (2012) Molecular functions of syndecan-1 in disease. Matrix Biol. 31, 3-16.
75. Thompson C.A., Purushothaman A., Ramani V.C., Vlodavsky I. & Sanderson R.D. (2013) Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 288, 10093-10099.
76. Voyvodic P.L., Min D., Liu R. et al. (2014) Loss of syndecan-1 induces a pro-inflammatory phenotype in endothelial cells with a dysregulated response to atheroprotective flow. J. Biol. Chem. 289, 9547-9559.
77. Whiteford J.R., Ko S., Lee W. & Couchman J.R. (2008) Structural and cell adhesion properties of zebrafish syndecan-4 are shared with higher vertebrates. J. Biol. Chem. 283, 29322-29330.
78. Woods A., Couchman J.R. & Höök M. (1985) Heparan sulfate proteoglycans of rat embryo fibroblasts. A hydrophobic form may link cytoskeleton and matrix components. J. Biol. Chem. 260, 10872-10879.
79. Xiao J., Angsana J., Wen J. et al. (2012) Syndecan-1 displays a protective role in aortic aneurysm formation by modulating T cell-mediated responses. Arterioscler. Thromb. Vasc. Biol. 32, 386-396.
80. Xie J., Wang J., Li R. et al. (2012) Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction. J. Mol. Cell. Cardiol. 53, 250-258.
81. Yang Y., Yaccoby S., Liu W. et al. (2002) Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood 100, 610-617.
82. Zhang X., Wu C., Song J., Götte M. & Sorokin L. (2013) Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis. J. Immunol. 191, 4551-4561.
83. Zimmermann P., Zhang Z., Degeest G. et al. (2005) Syndecan recycling is controlled by syntenin-PIP2 interaction and Arf6. Dev. Cell 9, 377-388.